This site uses technical cookies and profiling third party cookies to offer a better user experience; third party cookies require your consent. By continuing to browse the site, clicking or tapping the screen, scrolling the web page or closing this banner, you are agreeing to our use of cookies. For further information or opt out options.
IMA is loading

Main Financial Data 2017

Main Data: 31/12 Year 2017
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenue 1,444.73
– industrial gross profit  541.27
– total operating cost 376.05
– operating profit 165.22
– net financial expense 15.92
– profit attributable to equity holders of the parent 85.59

 

Consolidated balance sheet Millions/Euro
– working capital 26.82
– non-current assets 501.28
– provision for severance indemnities and other provisions -87.52
– net debt -50.05
– equity pertaining to the group and minority interests 390.53

 

Other information Millions/Euro
– depreciation and amortization  42.46
– R & D costs 53.99

 

  Euro
Dividend per share 1.60

 

  No.
Employees 5,448

 

  Euro
Share capital 20,415,200

 

Net Sales By Sector: Year 2017
  Millions/Euro  
tea, food & other 727.10 50.3%
pharmaceutical 565.87 39.2%
tobacco packaging 151.76 10.5%
Total 1,444.73 100.0%

 

Net Sales by Country: Year 2017
  Millions/Euro  
E.U. (excluding Italy) 449.56 31.1%
Other European countries 118.81 8.2%
North America 247.00 17.1%
Asia & Middle East 312.30 21.6%
Other countries 151.82 10.5%
Total exports 1,279.49 88.5%
Italy 165.24 11.5%
Total 1,444.73 100.0%

 

Main Data: 30/06 Year 2017
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenue 654.6
– industrial gross profit  252.7
– total operating cost 190.0
– operating profit 62.7
– net financial expense 7.5
– profit attributable to equity holders of the parent 31.9

 

Consolidated balance sheet Millions/Euro
– working capital 54.7
– non-current assets 469.4
– provision for severance indemnities and other provisions -70.1
– net debt -221.8
– equity pertaining to the group and minority interests 232.2

 

Other information Millions/Euro
– depreciation and amortization  19.8
– R & D costs 26.7

 

  No.
Employees 5,382

 

  Euro
Share capital 20,415,200